BioEclipse Therapeutics, Inc.
FDA inspection history on file, 2025
- 1
- Form 483
Every document, by year
- Form 483
2025: one Form 483.
The story so far
Built from the dates and citations on the documents themselves.
- 2025One Form 483.
Cited most
Across all BioEclipse Therapeutics observations on file
- 21 CFR 312.50General responsibilities of sponsors1
The complete BioEclipse Therapeutics file.
All 1 documents as original PDFs. For supplier audits, diligence and inspection prep.
Documents
1 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2025-03-25 | 483 Form 483 | — | 1 | $99 |
Investigators on these documents
FEI number 3033709371 · most recent document Mar 25, 2025
About BioEclipse Therapeutics, Inc.
How many FDA Form 483s has BioEclipse Therapeutics, Inc. received?
FDA Intel has 1 Form 483 on file for BioEclipse Therapeutics, Inc.; the most recent is dated Mar 25, 2025.
When was BioEclipse Therapeutics, Inc. last inspected by FDA?
The most recent FDA inspection document on file for BioEclipse Therapeutics, Inc. is a Form 483 dated Mar 25, 2025.
What did FDA cite at BioEclipse Therapeutics, Inc.?
The regulations cited most in the observations on file for BioEclipse Therapeutics, Inc. are 21 CFR 312.50 (General responsibilities of sponsors), 1 time.